Claudia Meyer

Commercial Services

Consumer Services

Profile

Claudia Meyer worked as a Director of Regulatory Affairs at Amsterdam Molecular Therapeutics (AMT) Holding NV.
Prior to that, she obtained a doctorate degree from the University of Bonn.

Former positions of Claudia Meyer

Companies	Position	End
Amsterdam Molecular Therapeutics (AMT) Holding NV Amsterdam Molecular Therapeutics (AMT) Holding NV Miscellaneous Commercial ServicesCommercial Services Amsterdam Molecular Therapeutics (AMT) Holding NV engages in the development of human gene based therapies. The company has a product pipeline of several gene therapy products in development for hemophilia B, acute intermittent porphyria, Parkinson's disease and SanfilippoB. It is expected to be finally dissolved in September 2012. Amsterdam Molecular Therapeutics (AMT) Holding was founded by Sander J. H. van Deventer and John J. P. Kastelein on March 20, 1998 and is headquartered in Amsterdam, Netherlands.	General Counsel	11/03/2013

See the detail of Claudia Meyer's experience

Training of Claudia Meyer

University of Bonn

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies